menu

Self-blood Glucose Monitoring Market

Schedule Call

Self-blood Glucose Monitoring Market

Self-blood Glucose Monitoring Market by Product Type (Testing Strips, Lancets, and Blood Glucose Meters), by Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and by End User (Hospitals, Home Settings, and Diagnostic Centers) – Global Outlook & Forecast 2022-2030

GR - 770243 Category: Therapeutics

Number of pages: 100  |  Report Format: PDF  |  Published date: November 14, 2022

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030


Self-blood Glucose Monitoring Market Scope

Report Attribute

Details

Market size value in 2021

US$ 14.8 billion

Revenue forecast in 2030

US$ 29.58 billion

Growth Rate

CAGR of 7.50% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Segments covered

by product type, applications, end user, and region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

The global self-blood glucose monitoring market was pegged at US$ 14.8 billion in 2021 and is expected to witness a CAGR of 7.50 % during the forecast period. 

Market Fundamentals 

Diabetes is a chronic metabolic disease characterized by elevated levels of glucose in the blood. Using a self-glucose meter to examine and monitor own blood sugar levels is known as self-monitoring. Daily blood sugar monitoring can significantly enhance patients’ ability to manage diabetes. The blood sugar can be measured rapidly and easily using modern meters. In addition to diabetes patients, pre-diabetic and non-diabetic users who want to frequently monitor their health are increasing the demand for SBGM (self-blood glucose monitoring) devices. Since it enhances metabolic control and quality of life and lowers the risk of complications, hospitalization, and mortality, self-management is a crucial technique in the management of diabetes. Furthermore, it improves glycemic control and stops the spread of illnesses and related problems, thus making self-management behaviors essential.

[44353423]

Market Dynamics

The global self-blood glucose monitoring market is driven by rising prevalence of diabetes and obesity. Further, innovation in technologies leads to the launch of new devices by many market players. Moreover, self-monitoring blood glucose (SMBG) aids diabetes patients in determining the amount of insulin, the amount of food, and the kind of physical activity each day. However, limited access to devices in low- and middle-income countries can limit the growth of market in some areas. 

Market Ecosystem

The global self-blood glucose monitoring market has been analyzed from four perspectives: by product type, applications, end user, and region. 

Self-Blood Glucose Monitoring Market by Product Type

[3213123]

Based on product types, the global self-blood glucose monitoring market is segmented into test strips, lancets, and blood glucose meters. The test strips segment has dominated the market. The test strips help to test blood sugar level. These test strips are disposable plastic strips which seem trivial, yet they play a critical role in helping diabetics monitor and manage their condition. The lancet segment is expected to grow with a high CAGR in the forecast period. The lancet is a finger-stick blood sampler which tests the blood glucose level in the blood. Lancets are advantageous as these are specific and personalized for every patient type. 

Self-blood Glucose Monitoring Market by Application

Based on applications, the market for self-blood glucose monitoring is segmented into type 1, type 2, and gestational diabetes. Among these, application in type 2 diabetes has gained largest revenue share. Type 2 diabetes is associated with high blood pressure and obesity. The risk of type 2 diabetes seems to increase with hypertension which can alter the insulin levels in the body. Obesity is another leading cause of type 2 diabetes presence of NEFA, glycerol, hormones, cytokines, proinflammatory chemicals, and other compounds are involved in the development of type 2 diabetes.  

Self-Blood Glucose Monitoring Market by Region

Based on region, the global self-blood glucose monitoring market has been segmented into North America, Europe, Asia Pacific, and the rest of the world. North America dominated the global self-blood glucose monitoring market in 2021. Factors contributing to the prominence are prevalence of diabetes, launch of new diabetic device in the market. The primary factors influencing the European market are the high number of children and adolescents affected with diabetes which makes monitoring more necessary. The International Diabetes Federation in 2021 states that the European region has about 295,000 children and adolescents suffering from insulin dependent diabetes. Asia Pacific is characterized by large number of patients suffering from diabetes, increased number of obesities leading to diabetes and growing disposable incomes and healthcare expenditure. According to the International Diabetes Federation, in 2021, 90 million persons were affected with diabetes in Southeast Asia. By 2030 and 2045, this number is projected to rise to 113 million and 152 million, respectively. Anticipation of such humongous burden will urge the market players to quickly introduce their conventional and novel products in the Asia Pacific market and thus facilitate rapid market growth. 

Competitive Landscape

Some of the prominent players operating in the self-blood glucose monitoring market are 

  • Bionime Corporation
  • Ypsomed Holding AG
  • PHC Holdings Corporation
  • Trividia Health, Inc. 
  • Lifescan Holdings LLC
  • F. Hoffman-La Roche Ltd.
  • Abbott Laboratories
  • Arkray, Inc. 
  • Braun Melsungen AG
  • Terumo Medical Corporation

Frequently Asked Questions About This Report

The global self-blood glucose monitoring market is driven by rising prevalence of diabetes, high government initiatives for the disease

Some of the prominent players operating in the self-blood glucose monitoring market are Bionime Corporation, Ypsomed Holding AG, PHC Holdings Corporation, Trividia Health Inc., Lifescan Holdings LLC, F. Hoffman-La Roche Ltd., Abbott Laboratories Inc., Arkray Inc., Braun Melsungen AG, and Terumo Medical Corporation

The global self-blood glucose monitoring market was pegged at US$ 14.8 billion in 2021 and is expected to witness a CAGR of 7.50 % during the forecast period.

Limited access to devices in low- and middle-income countries can limit the growth of market in some areas.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Base Year – 2021
      2. Historical Years – 2020
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1.    Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
  5. GLOBAL SELF-BLOOD GLUCOSE MONITORING MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
    1. Test Strips
    2. Lancets
    3. Blood Glucose Meters
  6. GLOBAL SELF-BLOOD GLUCOSE MONITORING MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Type 1 Diabetes
    2. Type 2 Diabetes
    3. Gestational Diabetes
  7. GLOBAL SELF-BLOOD GLUCOSE MONITORING MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospitals
    2. Home Settings
    3. Diagnostic Centers
  8. GLOBAL SELF-BLOOD GLUCOSE MONITORING MARKET- ANALYSIS & FORECAST, BY REGION
    1. North America Self-blood Glucose Monitoring Market
      1. North America Self-blood Glucose Monitoring Market, by Product Type
      2. North America Self-blood Glucose Monitoring Market, by Application
      3. North America Self-blood Glucose Monitoring Market, End User
      4. North America Self-blood Glucose Monitoring Market, by Country
        1. U.S.
          1. U.S. Self-blood Glucose Monitoring Market, by Product Type
          2. U.S. Self-blood Glucose Monitoring Market, by Application 
          3. U.S. Self-blood Glucose Monitoring Market, End User
        2. Canada
          1. Canada Self-blood Glucose Monitoring Market, by Product Type
          2. Canada Self-blood Glucose Monitoring Market, by Application 
          3. Canada Self-blood Glucose Monitoring Market, End User
    2. Europe Self-blood Glucose Monitoring Market
      1. Europe Self-blood Glucose Monitoring Market, by Product Type
      2. Europe Self-blood Glucose Monitoring Market, by Application
      3. Europe Self-blood Glucose Monitoring Market, End User
      4. Europe Self-blood Glucose Monitoring Market, by Country/Region
        1. Germany
          1. Germany Self-blood Glucose Monitoring Market, by Product Type
          2. Germany Self-blood Glucose Monitoring Market, by Application
          3. Germany Self-blood Glucose Monitoring Market, End User
        2. U.K
          1. U.K Self-blood Glucose Monitoring Market, by Product Type
          2. U.K Self-blood Glucose Monitoring Market, by Application
          3. U.K Self-blood Glucose Monitoring Market, End User
        3. France
          1. France Self-blood Glucose Monitoring Market, by Product Type
          2. France Self-blood Glucose Monitoring Market, by Application
          3. France Self-blood Glucose Monitoring Market, End User
        4. Spain
          1. Spain Self-blood Glucose Monitoring Market, by Product Type
          2. Spain Self-blood Glucose Monitoring Market, by Application
          3. Spain Self-blood Glucose Monitoring Market, End User
        5. Italy
          1. Italy Self-blood Glucose Monitoring Market, by Product Type
          2. Italy Self-blood Glucose Monitoring Market, by Application
          3. Italy Self-blood Glucose Monitoring Market, End User
        6. Rest of Europe
          1. Rest of Europe Self-blood Glucose Monitoring Market, by Product Type
          2. Rest of Europe Self-blood Glucose Monitoring Market, by Application
          3. Rest of Europe Self-blood Glucose Monitoring Market, End User
    3. Asia Pacific Self-blood Glucose Monitoring Market
      1. Asia Pacific Self-blood Glucose Monitoring Market, by Product Type
      2. Asia Pacific Self-blood Glucose Monitoring Market, by Application
      3. Asia Pacific Self-blood Glucose Monitoring Market, End User 
      4. Asia Pacific Self-blood Glucose Monitoring Market, by Country/Region
        1. China
          1. China Self-blood Glucose Monitoring Market, by Product Type
          2. China Self-blood Glucose Monitoring Market, by Application
          3. China Self-blood Glucose Monitoring Market, End User
        2. Japan
          1. Japan Self-blood Glucose Monitoring Market, by Product Type
          2. Japan Self-blood Glucose Monitoring Market, by Application
          3. Japan Self-blood Glucose Monitoring Market, End User
        3. India
          1. India Self-blood Glucose Monitoring Market, by Product Type
          2. India Self-blood Glucose Monitoring Market, by Application
          3. India Self-blood Glucose Monitoring Market, End User
        4. South Korea
          1. South Korea Self-blood Glucose Monitoring Market, by Product Type
          2. South Korea Self-blood Glucose Monitoring Market, by Application
          3. South Korea Self-blood Glucose Monitoring Market, End User
        5. Australia
          1. Australia Self-blood Glucose Monitoring Market, by Product Type
          2. Australia Self-blood Glucose Monitoring Market, by Application
          3. Australia Self-blood Glucose Monitoring Market, End User
        6. Rest of Asia Pacific 
          1. Rest of Asia Pacific Self-blood Glucose Monitoring Market, by Product Type
          2. Rest of Asia Pacific Self-blood Glucose Monitoring Market, by Application
          3. Rest of Asia Pacific Self-blood Glucose Monitoring Market, End User
    4. Rest of the World Self-blood Glucose Monitoring Market
      1. Rest of the World Self-blood Glucose Monitoring Market, by Product Type
      2. Rest of the World Self-blood Glucose Monitoring Market, by Application
      3. Rest of the World Self-blood Glucose Monitoring Market, by End User
      4. Rest of the World Self-blood Glucose Monitoring Market, by Region
        1. Latin America
          1. Latin America Self-blood Glucose Monitoring Market, by Product Type
          2. Latin America Self-blood Glucose Monitoring Market, by Application
          3. Latin America Self-blood Glucose Monitoring Market, End User
        2. Middle East & Africa
          1. Middle America & Africa Self-blood Glucose Monitoring Market, by Product Type
          2. Middle America & Africa Self-blood Glucose Monitoring Market, by Application
          3. Middle America & Africa Self-blood Glucose Monitoring Market, End User
  9. COMPANY PROFILES                
    1. Bionime Corporation
      1. Business Snapshot
      2. Products Offered
      3. Financial Details*
      4. Strategic Development
    2. Ypsomed Holding AG
    3. PHC Holdings Corporation
    4. Trividia Health, Inc. 
    5. Lifescan Holdings LLC
    6. F. Hoffman-La Roche Ltd.
    7. Abbott Laboratories
    8. Arkray, Inc. 
    9. Braun Melsungen AG
    10. Terumo Medical Corporation

 

*Insights on financial performance is subject to availability of information in public domain


Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Self-blood Glucose Monitoring Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Self-blood Glucose Monitoring Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports